Europe E-Pharmacy Market - Industry Outlook & Forecast 2023-2028

273 pages

98 tables

114 charts

3 region

15 countries

49 company

5 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE EUROPE E-PHARMACY MARKET SIZE IS EXPECTED TO REACH USD 65.47 BILLION BY 2028 FROM USD 24.69 BILLION IN 2022, GROWING AT A CAGR OF 17.65% DURING THE FORECAST PERIOD.

Europe E-Pharmacy Market Size, Share, and Trends Analysis

  • Medicine Type: OTC and Prescription
  • Platform: Mobile and Desktop
  • Age Group: Below 50 and Above 50
  • Product: Medications, Health & Wellness and Nutrition, Personal Care & Essentials, and Others
  • Geography: EU-4 & UK, Central and Eastern Europe, and Nordic Countries

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

EUROPE E-PHARMACY MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2028)USD 65.47 Billion
Market Size (2022)USD 24.69 Billion
CAGR (2022-2028)17.65%
Base Year2022
Forecast Year2023-2028
Market SegmentsMedicine Type, Platform, Age Group, Product, and Geography
Geographic AnalysisEU-4 & UK, Central and Eastern Europe, and Nordic Countries
KEY VENDORSDocMorris AG (Zur Rose Group) and Shop Apotheke
Interested in this Report?

Download a Sample!

INDUSTRY OVERVIEW

The Europe e-pharmacy market was valued at USD 24.69 billion in 2022 and is expected to reach USD 65.47 billion by 2028, growing at a CAGR of 17.65%. Europe is going through a major shift with a growing number of people suffering from chronic diseases. Patients are usually required to take their medicines over the long term. However, they end up not taking their medicines as prescribed due to the inconvenience of purchasing them or not finding pharmacy stores if they live in rural areas. Further, with busy lifestyles, healthcare often takes a backseat for most people. As a result of this struggle, people have started to turn to the Internet to order medicines, propelling the Europe e-pharmacy market growth.

E-pharmacies: the existence of an online pharmacy that offers medical care and solutions providers the ability to prescribe medicines for consumers online. In Europe, the European Association of E-pharmacies (EAEP) stated that the members of EAEP are continuously increasing and improving the quality, safety, and efficiency of healthcare delivery for Europe people. E-pharmacies are currently supplying millions of people across the region with medicine. Also, online medicine shoppers appreciate the transparency, cost benefits, east processes, and delivery to their homes and take advantage of discreet & high-quality pharmaceutical consulting services. The Europe e-pharmacy market is trending in most of the region’s developing and developed countries. The trend from offline to online is the future, and there is a major growth potential for online pharmacies in Southern European countries such as France, Germany, Italy, and Spain. The fastest-growing regional market in Germany due to the increasing internet penetration and rising awareness regarding online over-the-counter benefits.

Europe E-Pharmacy Market Report, Size Analysis

MARKET TRENDS & OPPORTUNITIES

Rapidly Growing E-Health & E-prescription
Due to the progressive nature of healthcare and medicine deliveries in Europe, the approach changing from hospital care to homecare deliveries offers huge opportunities in European patient management across all healthcare systems. Growing adoption of e-health solutions such as m-health, telemedicine, and e-prescription help consumers connect directly to health professionals and receive care and consultations at home. Increasing use of e-health applications and increasing allowance to e-prescription drive the high medicine purchasing orders through e-pharmacies that have recently accelerated the Europe e-pharmacy market growth.

Integration of AI, & IoT
Technologies such as artificial intelligence (AI), Machine Learning, and the Internet of Things can potentially make pharmacy technologies more powerful. Europe is a technology-driven market for healthcare systems and pharmaceutical industries. Pharmacies with AI, Machine Learning offer multiple benefits, such as data processing, enabling pharmacists to make quick data-backed decisions and improve customer services. Furthermore, with IoT, drug inventory management will be faster and more accurate; through device-to-device communication. To accelerate performance advancement, pharmacists must be skilled at using emerging technologies of all kinds.

Strategic Operations for Market Expansion by Vendors
The European e-pharmacy market is witnessing massive development with several business strategies implementation. Several strategic partnerships, collaborations, and mergers & acquisitions have been registered in the Europe e-pharmacy market in recent years. Some leading industry players are considering strategic and opportunistic acquisitions of other companies, businesses, or assets. In 2023, the leading industry player SHOP APOTHEKE EUROPE and Galenica entered into a strategic partnership and established MediService Ltd leading online pharmacy in Switzerland.

SEGMENTATION INSIGHTS

INSIGHTS BY MEDICINE TYPE
The Europe e-pharmacy market by medicine type is segmented into over-the-counter (OTC) and prescription. OTC medicine types, including health & wellness and nutrition, dietary supplements, personal care, and cosmetic care solutions, are commonly and majorly ordered by people. The OTC segment accounted for the largest segmental revenue share in 2022. In Europe, most countries experienced a high demand for OTC products. In 2018, Roblek et al. found that customer expresses three typical online behaviors of OTC drugs: searching for information about OTC medicines without any particular purpose, buying OTC medicines, and searching for particular products or information.

INSIGHTS BY PLATFORM
The mobile platform segment accounted for the largest revenue share in the Europe e-pharmacy market in 2022. The increasing prevalence of chronic diseases drives awareness about medications and therapies in developed countries such as Germany, France, Switzerland, Italy, the UK, Spain, and others witnessed increasing use of mobile devices and associated applications to buy medicines online. Online pharmacies are witnessing the high growth and demand for medicines through smartphones and tablets.

INSIGHTS BY AGE GROUP
The below-50 age group segment dominated the Europe e-pharmacy market share in 2022. The below-50 age group highly uses internet services & smartphones and highly prefers buying medicine from online pharmacies. The penetration of e-commerce shopping preference accelerates the higher segmental growth.

INSIGHTS BY PRODUCT
The Europe e-pharmacy market by product types includes medications, health & wellness and nutrition, personal care & essentials, and others. The medications segment accounted for the industry's highest revenue share of over 75% in 2022. Online pharmacies purchase mostly prescription drugs associated with viral infections such as cold and flu, cough, diabetes-associated drugs, cancer care drugs, etc. On another side, opioids, slimming tablets, and hypnotic and sedative agents are some of the prescription medicines highly sold in Europe.

REGIONAL ANALYSIS

EU-4 & UK is a major region in the Europe e-pharmacy market with high development in the pharmaceutical industry, research and development, production, sale, marketing, and distribution. The huge patient population and higher health expenditures by patients are accelerating the application of rate of e-pharmacy websites and mobile applications. In 2022, EU-4 & UK region accounted for the highest share of over 59% in the Europe e-pharmacy market. In EU-4 & UK region, major countries such as Germany and the UK have made major progress in the e-pharmacy network. The presence of major and emerging e-pharmacies accelerates regional growth. On another side, the growing patient population and rising expenditure on health propelling regional growth. Furthermore, Italy and Spain have shown rapid growth in e-pharmacies. Leading industry players such as shop-apotheke.com (SHOP APOTHEKE) state that Italy is a rapidly growing market for e-pharmacies due to increasing e-commerce and internet penetration simultaneously increasing in the country.

VENDOR LANDSCAPE

In the Europe e-pharmacy market, several local/traditional/offline and online pharmacies are present in the region, significantly driving the competitive rivalry. In addition, the access to e-commerce channels and their involvement in medication deliveries make the European e-pharmacy market highly competitive. The e-commerce channels allow European pharmacies to provide/offer a wider range of products than local pharmacies, not constrained by the amount of physical shelf storage space.

The industry is growing healthy as the online pharma distribution channel has become the most common way of buying OTC and prescription medical products, especially during the Covid-19 pandemic. There is a high penetration of the Europe e-pharmacy market in the Netherlands, the UK, Switzerland, and Germany in the European Union. Further, DocMorris (Zur Rose Group) and SHOP APOTHEKE from the Netherlands are key players in the Europe e-pharmacy market. They have fought court battles for market access and freedom to set their respective prices in the country. These two players have already acquired other major and minor players to increase their market share and use their resources to the optimum limit. They are using the acquisition strategy to expand in the industry.

Frequently Asked Questions

How big is the Europe e-pharmacy market?

The Europe e-pharmacy market size was valued at USD 24.69 billion in 2022 and is expected to reach USD 65.47 billion by 2028.

What is the growth rate of the Europe e-pharmacy market?

The Europe e-pharmacy market is growing at a CAGR of 17.65% from 2022-2028.

What are the growing trends in the Europe e-pharmacy market?

The growing trends in the Europe e-pharmacy market are rapidly growing e-health & e-prescription, integration of AI, & IoT, strategic operations for market expansion by vendors, and integrating e-pharmacies with a delivery management solution

Which region holds the most significant Europe e-pharmacy market share?

The EU-4 & UK dominated the Europe e-pharmacy market share, capturing a significant share of approximately 59% in 2022.

Who are the key players in the Europe e-pharmacy market?

DocMorris AG (Zur Rose Group) and Shop Apotheke are the key players in the Europe e-pharmacy market.

The Europe e-pharmacy market is expected to grow at a CAGR of approximately 17.65% from 2022 to 2028.

The following factors are likely to contribute to the growth of the Europe e-pharmacy market during the forecast period:

  • Internet Penetration Among Patient Population
  • Increasing Home Healthcare Deliveries
  • Growing Health Awareness & Self Medication
  • Rising Patient Population

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the Europe e-pharmacy market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Company Profiles

  • DocMorris AG (Zur Rose Group)
    • Business Overview
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Shop Apotheke

Other Prominent Vendors

  • AMX Holdings
    • Business Overview
    • Key Strategies
    • Key Strengths
  • Apteka.ru
  • Apotea
  • Apoteket
  • AZETA
  • BestPharmacy
  • Chemist4U
  • Chemist Direct
  • Cocooncenter
  • DeOnlineDrogist
  • ePharmacy (EAPTEKA)
  • Euro-Pharmas
  • Express Pharmacy
  • EVERER GmbH
  • Farmacia Internacional
  • Helsinki University Pharmacy [Yliopiston Apteekki] (YA)
  • Index Medical
  • INHOUSE PHARMACY
  • Juvalis
  • Lékárna WPK
  • Lloyds Pharmacy
  • Lekarnar
  • Lyf og heilsa hf.
  • Lyfjaver
  • MedExpress Enterprises
  • MonCoinSanté
  • Mistletoe Pharmacy
  • myCARE
  • MediService AG
  • Mediservice Ltd
  • MEDS
  • Newpharma
  • Oxford Online Pharmacy
  • Prvalekarna
  • Parafarmacia-online
  • Pharmacy2U
  • Pharmacy Direct GB
  • Pharm24
  • PROTEK Group
  • SBER EAPTEKA
  • Simple Online Pharmacy
  • The independent pharmacy
  • The French pharmacy
  • UK Meds Direct
  • WebMed Pharmacy
  • Pharmacy4u
  • Vamida

Segmentation by Medicine Type

  • OTC
  • Prescription

Segmentation by Platform

  • Mobile
  • Desktop

Segmentation by Age Group

  • Below 50
  • Above 50

Segmentation by Product

  • Medications
  • Health & Wellness and Nutrition
  • Personal Care & Essentials
  • Others

Segmentation by Geography

  • EU-4 & UK
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Central and Eastern Europe
    • Poland
    • Netherlands
    • Russia
    • Switzerland
    • Czech Republic
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
    • Finland
    • Iceland

EXHIBIT 1 SEGMENTATION OF EUROPE E-PHARMACY MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 EUROPE E-PHARMACY MARKET DYNAMICS (2022)

EXHIBIT 4 IMPACT OF INCREASED E-HEALTH & E-PRESCRIPTION SERVICES

EXHIBIT 5 IMPACT OF INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS

EXHIBIT 6 AI IN E-PHARMACY

EXHIBIT 7 IMPACT OF STRATEGIC ACQUISITIONS FOR MARKET EXPANSION

EXHIBIT 8 IMPACT OF INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS

EXHIBIT 9 SERVICES OFFERED BY PHARMACY DELIVERY SOFTWARE SOLUTIONS

EXHIBIT 10 IMPACT OF INTERNET PENETRATION AMONG PATIENT POPULATION

EXHIBIT 11 INTERNET USE IN EUROPE

EXHIBIT 12 EUROPEAN COUNTRIES WITH INTERNET USE & ONLINE PURCHASE ATTITUDE (2023)

EXHIBIT 13 IMPACT OF INCREASED HOME HEALTHCARE DELIVERIES

EXHIBIT 14 ADVANTAGES OF E-PHARMACIES IN HOMECARE SETTINGS

EXHIBIT 15 IMPACT OF INCREASED HEALTH AWARENESS & SELF-MEDICATION

EXHIBIT 16 IMPACT OF INCREASED PATIENT POPULATION

EXHIBIT 17 PEOPLE AGED 65 & ABOVE WITH CHRONIC DISEASE PREVALENCE BY COUNTRY (%): 2018

EXHIBIT 18 IMPACT OF STRINGENT REGULATORY NORMS

EXHIBIT 19 IMPACT OF DATA BREACH & PRIVACY ISSUES

EXHIBIT 20 IMPACT OF COMPETITION FROM TRADITIONAL PHARMACIES

EXHIBIT 21 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: MARKET SHARE 2022 & 2028

EXHIBIT 22 EUROPE E-PHARMACY MARKET BY PLATFORM: MARKET SHARE 2022 & 2028

EXHIBIT 23 EUROPE E-PHARMACY MARKET BY AGE GROUP: MARKET SHARE 2022 & 2028

EXHIBIT 24 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: MARKET SHARE 2022 & 2028

EXHIBIT 25 EUROPE E-PHARMACY MARKET BY REGION: MARKET SHARE 2022 & 2028

EXHIBIT 26 EUROPE E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 27 FIVE FORCES ANALYSIS 2022

EXHIBIT 28 INCREMENTAL GROWTH BY MEDICINE TYPE 2022 & 2028

EXHIBIT 29 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028

EXHIBIT 30 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: SEGMENTAL OVERVIEW

EXHIBIT 31 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH E-PHARMACIES

EXHIBIT 32 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: INCREMENTAL GROWTH

EXHIBIT 33 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: ABSOLUTE GROWTH

EXHIBIT 34 EUROPE OTC E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 35 EUROPE OTC E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 36 EUROPE RX E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 37 EUROPE RX E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 38 INCREMENTAL GROWTH BY PLATFORM 2022 & 2028

EXHIBIT 39 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028

EXHIBIT 40 EUROPE E-PHARMACY MARKET BY PLATFORM: SEGMENTAL OVERVIEW

EXHIBIT 41 EUROPE E-PHARMACY MARKET BY PLATFORM: INCREMENTAL GROWTH

EXHIBIT 42 EUROPE MOBILE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 43 EUROPE MOBILE E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 44 PERSONAL COMPUTER PENETRATION PER CAPITA IN WESTERN EUROPE (2014–2019)

EXHIBIT 45 DESKTOP PENETRATION IN THE UK (2015–2020)

EXHIBIT 46 EUROPE DESKTOP E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 47 EUROPE DESKTOP E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 48 INCREMENTAL GROWTH BY AGE GROUP 2022 & 2028

EXHIBIT 49 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028

EXHIBIT 50 THE EUROPE E-PHARMACY MARKET BY AGE GROUP SEGMENT: SEGMENTAL OVERVIEW

EXHIBIT 51 EUROPE E-PHARMACY MARKET BY AGE GROUP: INCREMENTAL GROWTH

EXHIBIT 52 EUROPE E-PHARMACY MARKET BY AGE GROUP: ABSOLUTE GROWTH

EXHIBIT 53 EUROPE BELOW 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 54 INTERNET USERS IN EUROPE BY AGE GROUP WHO BOUGHT/ORDERED GOODS & SERVICES ONLINE (2010–2022) (%)

EXHIBIT 55 POLAND E-PHARMACY VISITS BY AGE GROUP (2016)

EXHIBIT 56 EUROPE BELOW 50 E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 57 INTERNET USERS IN EUROPE BY AGE GROUP WHO ORDERED GOODS & SERVICES THROUGH E-COMMERCE WEBSITES: 2010 TO 2022 (%)

EXHIBIT 58 POLAND ONLINE PHARMACY VISITS BY AGE GROUP 2016

EXHIBIT 59 EUROPE ABOVE 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 60 EUROPE ABOVE 50 E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 61 INCREMENTAL GROWTH BY PRODUCT TYPE 2022 & 2028

EXHIBIT 62 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028

EXHIBIT 63 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: SEGMENTAL OVERVIEW

EXHIBIT 64 EUROPE E-COMMERCE PURCHASE BY PRODUCT CATEGORY: 2021 (%)

EXHIBIT 65 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH

EXHIBIT 66 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH

EXHIBIT 67 PURCHASED MEDICATION PREFERENCE THROUGH E-PHARMACIES

EXHIBIT 68 EUROPE MEDICATION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 69 EUROPE MEDICATION E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 70 TOP 10 NUTRITIONAL SUPPLEMENTS CONSUMED BY EUROPEANS (2022)

EXHIBIT 71 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 72 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 73 EUROPE PERSONAL CARE & COSMETIC PRODUCT EXPENDITURE: 2021 (BILLION)

EXHIBIT 74 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 75 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 76 EUROPE OTHERS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 77 EUROPE OTHERS E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 78 INCREMENTAL GROWTH BY REGION 2022 & 2028

EXHIBIT 79 EUROPE E-PHARMACY MARKET BY REGION 2022–2028

EXHIBIT 80 INTERNET USERS & E-SHOPPERS IN EU-4 & UK (2021)

EXHIBIT 81 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH ONLINE PHARMACIES

EXHIBIT 82 EU-4 & UK E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 83 EU-4 & UK E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 84 INCREMENTAL GROWTH IN EU-4 & UK 2022 & 2028

EXHIBIT 85 SEARCH FOR E-PHARMACIES IN GERMANY: JANUARY 2020 TO JANUARY 2021 (%)

EXHIBIT 86 GERMANY E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 87 UK E-PRESCRIPTION STATISTICS (2019)

EXHIBIT 88 UK E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 89 NON-PRESCRIPTION MEDICINE SALES THROUGH E-PHARMACIES: ONLINE DRUGS SALES REGULATION

EXHIBIT 90 WILLINGNESS TO PURCHASE MEDICINES ONLINE: FRANCE

EXHIBIT 91 FRANCE E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 92 OPINION ABOUT ONLINE SALE OF MEDICINES IN ITALY (2019)

EXHIBIT 93 ITALY E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 94 SPAIN E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 95 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 96 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 97 INCREMENTAL GROWTH IN CENTRAL & EASTERN EUROPE 2022 & 2028

EXHIBIT 98 POLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 99 NETHERLANDS FACTS (2020)

EXHIBIT 100 NETHERLANDS E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 101 RUSSIA E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 102 SWITZERLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 103 INTERNET PENETRATION: CZECH REPUBLIC (2021)

EXHIBIT 104 CZECH REPUBLIC E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 105 NORDIC COUNTRIES E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 106 NORDIC COUNTRIES E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 107 INCREMENTAL GROWTH IN NORDIC COUNTRIES 2022 & 2028

EXHIBIT 108 DENMARK: ALLOCATION OF DIFFERENT ENTITIES OF PHARMACIES (2020)

EXHIBIT 109 DENMARK E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 110 SWEDEN PHARMACY & E-PHARMACY STATISTICS (2022)

EXHIBIT 111 SWEDEN E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 112 NORWAY E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 113 FINLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)

EXHIBIT 114 ICELAND E-PHARMACY MARKET 2022–2028 ($ BILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2016–2022

TABLE 3 E-PRESCRIPTION GENERATION IN EUROPEAN COUNTRIES

TABLE 4 EUROPE E-PHARMACY MARKET: STRATEGIC PARTNERSHIPS, M&A & COLLABORATIONS

TABLE 5 SELF-MEDICATION PREVALENCE BY THERAPY AREAS IN EUROPEAN COUNTRIES (2020)

TABLE 6 DATA BREACHING & CYBERATTACK ISSUES

TABLE 7 EUROPE E-PHARMACY MARKET: SEGMENTAL DATA COMPARISON (2022–2028)

TABLE 8 EUROPE OTC E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 9 EUROPE OTC E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 10 EUROPE RX E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 11 EUROPE RX E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 12 EUROPE SMARTPHONE PENETRATION & USERS (2021)

TABLE 13 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 14 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 15 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 16 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 17 RESPONDENTS WHO PURCHASED MEDICINE THROUGH ONLINE PHARMACIES IN EUROPE (2021)

TABLE 18 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 19 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 20 RESPONDENTS WHO PURCHASED MEDICINE FROM ONLINE PHARMACIES IN EUROPE (2021)

TABLE 21 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 22 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 23 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 24 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 25 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 26 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 27 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 28 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 29 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 30 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 31 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 32 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 33 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 34 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 35 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 36 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 37 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 38 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 39 SOME LEADING E-PHARMACIES IN GERMANY (2023)

TABLE 40 SOME LEADING ONLINE PHARMACIES IN ITALY

TABLE 41 SOME LEADING E-PHARMACIES IN SPAIN (2022)

TABLE 42 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 43 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 44 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 45 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 46 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 47 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 48 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 49 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 50 CONSUMER OPINIONS ON ONLINE SALES OF MEDICINE BY AGE GROUP IN RUSSIA: 2020–2021 (%)

TABLE 51 TOP FIVE PRESCRIPTION DELIVERY APPS & WEBSITES: SWITZERLAND

TABLE 52 COMPARISON OF E-PHARMACY MARKET IN NORDIC COUNTRIES

TABLE 53 INTERNET PENETRATION IN NORDIC COUNTRIES

TABLE 54 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 55 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 56 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 57 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 58 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 59 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 60 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 61 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 62 NORWAY: OVERVIEW OF ONLINE SALE OF MEDICINES

TABLE 63 CURRENT MARKET LANDSCAPE OF E-PHARMACY IN NORWAY

TABLE 64 TRADITIONAL PHARMACY & E-PHARMACY SERVICES MARKET SHARE IN ICELAND

TABLE 65 EUROPE E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)

TABLE 66 EUROPE E-PHARMACY MARKET BY REGION 2022–2028 (%)

TABLE 67 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 68 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 69 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 70 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 71 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 72 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 73 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 74 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 75 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 76 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 77 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 78 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 79 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 80 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 81 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 82 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 83 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 84 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 85 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 86 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 87 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 88 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 89 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 90 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

TABLE 91 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)

TABLE 92 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)

TABLE 93 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)

TABLE 94 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)

TABLE 95 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)

TABLE 96 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)

TABLE 97 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)

TABLE 98 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY MEDICINE TYPE

4.3.2 MARKET SEGMENTATION BY PLATFORM

4.3.3 MARKET SEGMENTATION BY PRODUCT TYPE

4.3.4 MARKET SEGMENTATION BY AGE GROUP

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 PREMIUM INSIGHTS

6.1 OVERVIEW

 

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

8.1.1 EUROPE E-PHARMACY MARKET OUTLOOK

8.1.2 GLOBAL E-PHARMACY MARKET OUTLOOK

 

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASED E-HEALTH & E-PRESCRIPTION SERVICES

9.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS

9.3 STRATEGIC ACQUISITIONS FOR MARKET EXPANSION

9.4 INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS

 

10 MARKET GROWTH ENABLERS

10.1 INTERNET PENETRATION AMONG PATIENT POPULATION

10.2 INCREASED HOME HEALTHCARE DELIVERIES

10.3 INCREASED HEALTH AWARENESS & SELF-MEDICATION

10.4 INCREASED PATIENT POPULATION

 

11 MARKET RESTRAINTS

11.1 STRINGENT REGULATORY NORMS

11.2 DATA BREACH & PRIVACY ISSUES

11.3 COMPETITION FROM TRADITIONAL PHARMACIES

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.1.1 MARKET BY MEDICINE TYPE

12.1.2 MARKET BY PLATFORM

12.1.3 MARKET BY AGE GROUP

12.1.4 MARKET BY PRODUCT TYPE

12.1.5 MARKET BY REGION

12.2 MARKET SIZE & FORECAST

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 MEDICINE TYPE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 OTC

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 RX

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

 

14 PLATFORM

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 MOBILE

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 DESKTOP

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

 

15 AGE GROUP

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 BELOW 50

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 ABOVE 50

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

 

16 PRODUCT TYPE

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 MEDICATION

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 HEALTH, WELLNESS & NUTRITION

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 PERSONAL CARE & ESSENTIALS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

16.6 OTHERS

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.6.3 MARKET BY GEOGRAPHY

 

17 REGION

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 REGIONAL OVERVIEW

 

18 EU-4 & UK

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 MEDICINE TYPE

18.3.1 MARKET SIZE & FORECAST

18.4 PLATFORM

18.4.1 MARKET SIZE & FORECAST

18.5 AGE GROUP

18.5.1 MARKET SIZE & FORECAST

18.6 PRODUCT TYPE

18.6.1 MARKET SIZE & FORECAST

18.7 KEY COUNTRIES

18.7.1 GERMANY: MARKET SIZE & FORECAST

18.7.2 UK: MARKET SIZE & FORECAST

18.7.3 FRANCE: MARKET SIZE & FORECAST

18.7.4 ITALY: MARKET SIZE & FORECAST

18.7.5 SPAIN: MARKET SIZE & FORECAST

 

19 CENTRAL & EASTERN EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 MEDICINE TYPE

19.3.1 MARKET SIZE & FORECAST

19.4 PLATFORM

19.4.1 MARKET SIZE & FORECAST

19.5 AGE GROUP

19.5.1 MARKET SIZE & FORECAST

19.6 PRODUCT TYPE

19.6.1 MARKET SIZE & FORECAST

19.7 KEY COUNTRIES

19.7.1 POLAND: MARKET SIZE & FORECAST

19.7.2 NETHERLANDS: MARKET SIZE & FORECAST

19.7.3 RUSSIA: MARKET SIZE & FORECAST

19.7.4 SWITZERLAND: MARKET SIZE & FORECAST

19.7.5 CZECH REPUBLIC: MARKET SIZE & FORECAST

 

20 NORDIC COUNTRIES

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 MEDICINE TYPE

20.3.1 MARKET SIZE & FORECAST

20.4 PLATFORM

20.4.1 MARKET SIZE & FORECAST

20.5 AGE GROUP

20.5.1 MARKET SIZE & FORECAST

20.6 PRODUCT TYPE

20.6.1 MARKET SIZE & FORECAST

20.7 KEY COUNTRIES

20.7.1 DENMARK: MARKET SIZE & FORECAST

20.7.2 SWEDEN: MARKET SIZE & FORECAST

20.7.3 NORWAY: MARKET SIZE & FORECAST

20.7.4 FINLAND: MARKET SIZE & FORECAST

20.7.5 ICELAND: MARKET SIZE & FORECAST

 

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

 

22 KEY COMPANY PROFILES

22.1 DOCMORRIS AG (ZUR ROSE GROUP)

22.1.1 BUSINESS OVERVIEW

22.1.2 KEY STRATEGIES

22.1.3 KEY STRENGTHS

22.1.4 KEY OPPORTUNITIES

22.2 SHOP APOTHEKE

22.2.1 BUSINESS OVERVIEW

22.2.2 KEY STRATEGIES

22.2.3 KEY STRENGTHS

22.2.4 KEY OPPORTUNITIES

 

23 OTHER PROMINENT VENDORS

23.1 AMX HOLDINGS

23.1.1 BUSINESS OVERVIEW

23.1.2 KEY STRATEGIES

23.1.3 KEY STRENGTHS

23.2 APTEKA.RU

23.2.1 BUSINESS OVERVIEW

23.2.2 KEY STRATEGIES

23.2.3 KEY STRENGTHS

23.3 APOTEA

23.3.1 BUSINESS OVERVIEW

23.3.2 KEY STRATEGIES

23.3.3 KEY STRENGTHS

23.4 APOTEKET

23.4.1 BUSINESS OVERVIEW

23.4.2 KEY STRATEGIES

23.4.3 KEY STRENGTHS

23.5 AZETA

23.5.1 BUSINESS OVERVIEW

23.5.2 KEY STRATEGIES

23.5.3 KEY STRENGTHS

23.6 BESTPHARMACY

23.6.1 BUSINESS OVERVIEW

23.6.2 KEY STRATEGIES

23.6.3 KEY STRENGTHS

23.7 CHEMIST4U

23.7.1 BUSINESS OVERVIEW

23.7.2 KEY STRATEGIES

23.7.3 KEY STRENGTHS

23.8 CHEMIST DIRECT

23.8.1 BUSINESS OVERVIEW

23.8.2 KEY STRATEGIES

23.8.3 KEY STRENGTHS

23.9 COCOONCENTER

23.9.1 BUSINESS OVERVIEW

23.9.2 KEY STRATEGIES

23.9.3 KEY STRENGTHS

23.10 DEONLINEDROGIST

23.10.1 BUSINESS OVERVIEW

23.10.2 KEY STRATEGIES

23.10.3 KEY STRENGTHS

23.11 EPHARMACY (EAPTEKA)

23.11.1 BUSINESS OVERVIEW

23.11.2 KEY STRATEGIES

23.11.3 KEY STRENGTHS

23.12 EURO-PHARAMAS

23.12.1 BUSINESS OVERVIEW

23.12.2 KEY STRATEGIES

23.12.3 KEY STRENGTHS

23.13 EXPRESS PHARMACY

23.13.1 BUSINESS OVERVIEW

23.13.2 KEY STRATEGIES

23.13.3 KEY STRENGTHS

23.14 EVERER GMBH

23.14.1 BUSINESS OVERVIEW

23.14.2 KEY STRATEGIES

23.14.3 KEY STRENGTHS

23.15 FRAMACIA INTERNACIONAL

23.15.1 BUSINESS OVERVIEW

23.15.2 KEY STRATEGIES

23.15.3 KEY STRENGTHS

23.16 HELSINKI UNIVERSITY PHARMACY [YLIOPISTAN APTEEKKI] (YA)

23.16.1 BUSINESS OVERVIEW

23.16.2 KEY STRATEGIES

23.16.3 KEY STRENGTHS

23.17 INDEX MEDICAL

23.17.1 BUSINESS OVERVIEW

23.17.2 KEY STRATEGIES

23.17.3 KEY STRENGTHS

23.18 INHOUSE PHARMACY

23.18.1 BUSINESS OVERVIEW

23.18.2 KEY STRATEGIES

23.18.3 KEY STRENGTHS

23.19 JUVALIS

23.19.1 BUSINESS OVERVIEW

23.19.2 KEY STRATEGIES

23.19.3 KEY STRENGTHS

23.20 LÉKÁRNA WPK

23.20.1 BUSINESS OVERVIEW

23.20.2 KEY STRATEGIES

23.20.3 KEY STRENGTHS

23.21 LLOYDS PHARMACY

23.21.1 BUSINESS OVERVIEW

23.21.2 KEY STRATEGIES

23.21.3 KEY STRENGTHS

23.22 LEKARNAR

23.22.1 BUSINESS OVERVIEW

23.22.2 KEY STRATEGIES

23.22.3 KEY STRENGTHS

23.23 LYF OG HEILSA

23.23.1 BUSINESS OVERVIEW

23.23.2 KEY STRATEGIES

23.23.3 KEY STRENGTHS

23.24 LYFJAVER

23.24.1 BUSINESS OVERVIEW

23.24.2 KEY STRATEGIES

23.24.3 KEY STRENGTHS

23.25 MEDEXPRESS ENTERPRISES

23.25.1 BUSINESS OVERVIEW

23.25.2 KEY STRATEGIES

23.25.3 KEY STRENGTHS

23.26 MONCOINSANTÉ

23.26.1 BUSINESS OVERVIEW

23.26.2 KEY STRATEGIES

23.26.3 KEY STRENGTHS

23.27 MISTLETOE PHARMACY

23.27.1 BUSINESS OVERVIEW

23.27.2 KEY STRATEGIES

23.27.3 KEY STRENGTHS

23.28 MYCARE

23.28.1 BUSINESS OVERVIEW

23.28.2 KEY STRATEGIES

23.28.3 KEY STRENGTHS

23.29 MEDISERVICE AG

23.29.1 BUSINESS OVERVIEW

23.29.2 KEY STRATEGIES

23.29.3 KEY STRENGTHS

23.30 MEDSERVICE LTD

23.30.1 BUSINESS OVERVIEW

23.30.2 KEY STRATEGIES

23.30.3 KEY STRENGTHS

23.31 MEDS

23.31.1 BUSINESS OVERVIEW

23.31.2 KEY STRATEGIES

23.31.3 KEY STRENGTHS

23.32 NEWPHARMA

23.32.1 BUSINESS OVERVIEW

23.32.2 KEY STRATEGIES

23.32.3 KEY STRENGTHS

23.33 OXFORD ONLINE PHARMACY

23.33.1 BUSINESS OVERVIEW

23.33.2 KEY STRATEGIES

23.33.3 KEY STRENGTHS

23.34 PRVALEKARNA

23.34.1 BUSINESS OVERVIEW

23.34.2 KEY STRATEGIES

23.34.3 KEY STRENGTHS

23.35 PARAFARMACIA-ONLINE

23.35.1 BUSINESS OVERVIEW

23.35.2 KEY STRATEGIES

23.35.3 KEY STRENGTHS

23.36 PHARMACY2U

23.36.1 BUSINESS OVERVIEW

23.36.2 KEY STRATEGIES

23.36.3 KEY STRENGTHS

23.37 PHARMACY DIRECT GB

23.37.1 BUSINESS OVERVIEW

23.37.2 KEY STRATEGIES

23.37.3 KEY STRENGTHS

23.38 PHARMA24

23.38.1 BUSINESS OVERVIEW

23.38.2 KEY STRATEGIES

23.38.3 KEY STRENGTHS

23.39 PROTEK GROUP

23.39.1 BUSINESS OVERVIEW

23.39.2 KEY STRATEGIES

23.39.3 KEY STRENGTHS

23.40 SBER EAPTEKA

23.40.1 BUSINESS OVERVIEW

23.40.2 KEY STRATEGIES

23.40.3 KEY STRENGTHS

23.41 SIMPLE ONLINE PHARMACY

23.41.1 BUSINESS OVERVIEW

23.41.2 KEY STRATEGIES

23.41.3 KEY STRENGTHS

23.42 THE INDEPENDENT PHARMACY

23.42.1 BUSINESS OVERVIEW

23.42.2 KEY STRATEGIES

23.42.3 KEY STRENGTHS

23.43 THE FRENCH PHARMACY

23.43.1 BUSINESS OVERVIEW

23.43.2 KEY STRATEGIES

23.43.3 KEY STRENGTHS

23.44 UK MEDS DIRECT

23.44.1 BUSINESS OVERVIEW

23.44.2 KEY STRATEGIES

23.44.3 KEY STRENGTHS

23.45 WEBMED PHARMACY

23.45.1 BUSINESS OVERVIEW

23.45.2 KEY STRATEGIES

23.45.3 KEY STRENGTHS

23.46 PHARMACY4U

23.46.1 BUSINESS OVERVIEW

23.46.2 KEY STRATEGIES

23.46.3 KEY STRENGTHS

23.47 VAMIDA

23.47.1 BUSINESS OVERVIEW

23.47.2 KEY STRATEGIES

23.47.3 KEY STRENGTHS

 

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS

24.2 STRATEGIC RECOMMENDATIONS

 

25 QUANTITATIVE SUMMARY

25.1 MARKET BY REGION

25.2 MARKET BY MEDICINE TYPE

25.3 MARKET BY PLATFORM

25.4 MARKET BY AGE GROUP

25.5 MARKET BY PRODUCT TYPE

25.6 EU-4 & UK: MARKET SEGMENTATION

25.6.1 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE

25.6.2 EU-4 & UK E-PHARMACY MARKET BY PLATFORM

25.6.3 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP

25.6.4 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE

25.7 CENTRAL & EASTERN EUROPE: MARKET SEGMENTATION

25.7.1 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE

25.7.2 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM

25.7.3 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP

25.7.4 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE

25.8 NORDIC COUNTRIES: MARKET SEGMENTATION

25.8.1 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE

25.8.2 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM

25.8.3 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP

25.8.4 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE

 

26 APPENDIX

26.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the Europe e-pharmacy market?

The Europe e-pharmacy market size was valued at USD 24.69 billion in 2022 and is expected to reach USD 65.47 billion by 2028.

What is the growth rate of the Europe e-pharmacy market?

The Europe e-pharmacy market is growing at a CAGR of 17.65% from 2022-2028.

What are the growing trends in the Europe e-pharmacy market?

The growing trends in the Europe e-pharmacy market are rapidly growing e-health & e-prescription, integration of AI, & IoT, strategic operations for market expansion by vendors, and integrating e-pharmacies with a delivery management solution

Which region holds the most significant Europe e-pharmacy market share?

The EU-4 & UK dominated the Europe e-pharmacy market share, capturing a significant share of approximately 59% in 2022.

Who are the key players in the Europe e-pharmacy market?

DocMorris AG (Zur Rose Group) and Shop Apotheke are the key players in the Europe e-pharmacy market.